Hawaii Association of Professional Nurses
Stay Connected
Become a member

ONLINE: 27th Annual Pharmacological Conference for Advanced Practice Providers: Enduring Modules

Posted over 1 year ago by Rick Ramirez in Education

Aloha All,

Please see below for this great way to get Pharmacology Credits!

27th Annual Pharmacological Conference for Advanced Practice Providers
Pharmacological Management of Clients across the Lifespan
Enduring Modules
Release date: September 9th, 2022
Expiration date: September 8th, 2023
Fee: $60 per module

Course ID Module Action
     
22CE00074 COVID & Antibiotics Enduring Module
3.0 ANCC, 3.0 Pharmacotherapeutic, 3.0 AAPA		 Register/Login
22CE00075 Mental Health Enduring Module
3.0 ANCC, 3.0 Pharmacotherapeutic, 3.0 AAPA		 Register/Login
22CE00076 Pain Management & PDMP Enduring Module
3.0 ANCC, 3.0 Pharmacotherapeutic, 3.0 AAPA		 Register/Login
22CE00077 Hot Off the Press Enduring Module
3.0 ANCC, 3.0 Pharmacotherapeutic, 3.0 AAPA		 Register/Login

Target Audience:

Nurse practitioners, advanced practice nurses, physician assistants,
primary care providers, and other interested healthcare professionals.

 

Purpose:

The purpose of this enduring material is to enable the learner to use state-of-the-art clinical knowledge about pharmacology to manage selected, complex, acute, and chronic patient populations across the life span.

 Global Outcomes:

  • Discuss medical management approaches for the treatment of co-infections and secondary infections in patients with COVID-19 including evidence-based guidelines for antimicrobials and vaccinations using a case-based approach
  • Articulate best practice options when initiating mental health pharmaceuticals within primary care settings while considering patient health status and existing conditions pending psychiatric referral
  • Describe updates related to pharmacotherapeutics commonly prescribed in primary care for opioid and non-opioid management considering the PDMP and other existing conditions
  • Identify new approaches in primary care for comprehensive medication management when addressing multiple comorbidities such as afib, heart failure, cancers, and other ailments

 

Method of Participation
The estimated time to complete the activity is 180 minutes.

  • Read this front matter information
  • Register for activity
  • Click on Course Materials tab
  • Enter User ID and Password (issued after registering) and click "Login"
  • Participate in the entire learning activity
  • Complete the online evaluation for activity
  • Complete the post-test with a score of 7 out of 9 or better
  • Upon successful completion of the post-test and evaluation your certificate of completion will be available to print or save.

Disclosure Information
As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education.  Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.

All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.